Research Article
Rosiglitazone Protects against Acetaminophen-Induced Acute Liver Injury by Inhibiting Multiple Endoplasmic Reticulum Stress Pathways
Figure 1
Pretreatment with rosiglitazone (RSG) prevented APAP-induced acute liver injury and reduced mortality. (a, b) Pretreatment with RSG reversed APAP-induced elevations in serum ALT (a) and AST (b). (c) Pretreatment with RSG prevented APAP-induced depletion of hepatocellular GSH. All data are expressed as (). compared to the control group (0 time point), ¶¶ compared to the APAP group at the same time point. (d) Rosiglitazone pretreatment reduced APAP-induced mortality.
(a) |
(b) |
(c) |
(d) |